1. Australia worries about Trump's threat to raise pharmaceutical import tariffs significantly. 2. Tariff increases could impact global markets, including the S&P 500's health sector.
Increased tariffs may negatively affect healthcare stocks within the S&P 500, reminiscent of prior tariff-related declines.
Tariff threats can shake investor confidence, influencing prices across the S&P 500, especially in relevant sectors.
The repercussions of tariffs on trade relations can have lasting effects on market stability, notably in healthcare.